In the last trading session, 1.82 million Onconetix Inc (NASDAQ:ONCO) shares changed hands as the company’s beta touched 3.07. With the company’s per share price at $0.07 changed hands at $0.0 or 0.00% during last session, the market valuation stood at $1.05M. ONCO’s last price was a discount, traded about -30471.43% off its 52-week high of $21.40. The share price had its 52-week low at $0.06, which suggests the last value was 14.29% up since then. When we look at Onconetix Inc’s average trading volume, we note the 10-day average is 12.8 million shares, with the 3-month average coming to 6.77 million.

Onconetix Inc (NASDAQ:ONCO) trade information

The company’s shares are showing year-to-date downside of -88.57%, with the 5-day performance at -7.69% in the red. However, in the 30-day time frame, Onconetix Inc (NASDAQ:ONCO) is -68.70% down. Looking at the short shares, we see there were 0.74 million shares sold at short interest cover period of 0.32 days.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -116.38%.

ONCO Dividends

Onconetix Inc is expected to release its next quarterly earnings report in May.

Onconetix Inc (NASDAQ:ONCO)’s Major holders

If we look at who the major shareholders are, we find that insiders hold 35.43% of Onconetix Inc shares while 2.80% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 4.33%.

Among Mutual Funds, the top two as of Feb 28, 2025 were Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund . With 52.46 shares estimated at $3777.0 under it, the former controlled 0.36% of total outstanding shares. On the other hand, Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund held about 0.07% of the shares, roughly 9.94 shares worth around $715.0.